Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
May 06, 2024
MEL practitioners—and knowledge producers more generally—should adopt an approach that is attuned to a realistic model of the stages of the policy process and be ready to seize windows of opportunity to apply evidence. This may require navigating competing demands, recognizing tradeoffs, and making ...
Blog Post
April 05, 2024
As the Center for Global Development’s inaugural Evidence in Policy Fellow, I just finished an extended engagement to help increase data and evidence use in the State Department’s Office of Foreign Assistance. While at State, I spent much of my time leading and participating in the work of the inter...
Blog Post
March 29, 2024
The US foreign assistance data for FY 2022 is nearly complete, except for some missing Department of Defense, Homeland Security, and Transportation data, and the data reveals some interesting trends. First, FY 2022 did not break the historical record of total obligations, but it came closer than any...
Blog Post
March 26, 2024
When we launched Pandemic Proof, many countries were still in the throes of the health and economic shocks of COVID-19. Lessons learned from the pandemic were still fresh. And the visibility and urgency of the pandemic catalyzed some important policy action, including the establishment of innovative...
Blog Post
February 26, 2024
As most of the developing world struggles to increase, let alone maintain current levels of domestic health expenditure, getting more health for the money has never been more important. Building robust health technology assessment (HTA) systems to inform governments on which health technologies and ...
Blog Post
January 30, 2024
Since its launch in 2000, Gavi, the Vaccine Alliance, has leveraged three primary levers to expand equitable vaccine access in lower-income countries. First, Gavi supports introductions of new and underused vaccines. Second, Gavi helps scale equitable immunization coverage rates. Third, Gavi uses an...